Ascendia

  MARKET NEWS

Gattefossé Advances Animal Health Through Science & Innovation
MoonLake Secures up to $500 Million in Non-Dilutive Financing From Hercules Capital
Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of an Oral Once-Daily Treatment for Obstructive Sleep Apnea
Neurona Therapeutics Raises $102 Million to Fuel NRTX-1001 Phase 3 EPIC Epilepsy Trial & Advance Regenerative Cell Therapy Pipeline
BASF Launches Aroma Ingredients With Reduced Product Carbon Footprints
Greenwich LifeSciences Announces Positive Immune Response Data From Phase 3 Clinical Trial
Antag Therapeutics Initiates Phase 1a Trial of a First-in-Class GIPR Antagonist to Address Key Gaps in Obesity Treatment
Bend Bioscience Adds Commercial Spray Drying & Granulation in Georgia
Tiziana Life Sciences Announces Johns Hopkins University Commences Dosing Nasal Foralumab in Phase 2 Multiple Sclerosis Clinical Trial
Denali Therapeutics Announces Initiation of BLA Filing for Accelerated Approval

  EXPERT CONTENT & RESOURCES

How to Choose the Right CDMO for Your Pharmaceutical Project

How to Choose the Right CDMO for Your Pharmaceutical Project

This guide outlines the fundamental considerations to ensure your CDMO selection aligns with your project goals.

Understanding the Foundation of LNP Formulation Success

Understanding the Foundation of LNP Formulation Success

Download our eBook and discover everything you need to know about lipids for developing LNP therapies, including:….

Lyophilization Development: Quality by Design Approach

Lyophilization Development: Quality by Design Approach

Lyophilization, or freeze-drying, addresses stability challenges associated with complex APIs, biologics, microbiomes, gene therapies, viral vectors, liposomes, and nanoparticles……

Choosing the Right Particle for Your Nanomedicine Application

Choosing the Right Particle for Your Nanomedicine Application

Nanoparticles are revolutionizing the landscape of nanomedicine, enabling significant advancements in early detection, targeted drug delivery, disease monitoring, and imaging. Due to their nanoscale size, these particles….

  FEATURED EDITORIAL

  COMPANY PROFILE

Purisys is a proven leader in custom API synthesis and manufacturing. We bring more than 40 years of experience in commercial pharmaceutical production –everything you need to scale up quickly and smoothly, without delays. Our extensive experience can help you reach your goals. We have experience working with emerging biotech companies looking for a skilled outsourcing partner to take your compounds to trial and with  large pharma companies that want to outsource parts of their supply chain to increase efficiency and speed to market. Click here for more.

  WHITEPAPERS & WEBINARS

WEBINAR ON DEMAND: Precision at Scale: Enabling Novel Therapeutics With Nanoparticle Manufacturing

WEBINAR ON DEMAND: Precision at Scale: Enabling Novel Therapeutics With Nanoparticle Manufacturing

Watch this on-demand webinar to learn about the key steps and considerations in bringing novel nanoparticle-based therapeutics from early R&D to commercial stages. Drawing from our 20 years of experience in the CDMO space, we cover critical topics unique to nanomaterials…..

WEBINAR ON DEMAND: Advantages of Carbopol® Polymers in Oral Formulations

WEBINAR ON DEMAND: Advantages of Carbopol® Polymers in Oral Formulations

In this video, the Lubrizol team together with the IMCD US team takes you through formulation aspects of Carbopol® polymers as well as the results of a case study on an Acetaminophen oral suspension formulation.

  WHITEPAPERS & WEBINARS

WHITEPAPER - Efficient Development of Miniature Drug-Loaded Implants

WHITEPAPER - Efficient Development of Miniature Drug-Loaded Implants

Drug-eluting implants offer a unique approach to overcoming challenges associated with traditional drug delivery methods. They can provide sustained, continuous release of a therapeutic at the desired site of action.

Download our latest white paper, jointly authored with MeltPrep, to …

WHITEPAPER - 3D SCREEN Printing: Enabling a New Generation of Complex Formulations

WHITEPAPER - 3D SCREEN Printing: Enabling a New Generation of Complex Formulations

The pharmaceutical industry has been acquainted with the promise of 3D printing for some time now, with many large pharma companies exploring the possibilities of the technology. However, 3D-printed pharmaceuticals have been largely relegated to niche markets and prototyping due …

 WHITEPAPER - Formulating Custom Viscosity Blends With POLYOX™ Polyethylene Oxide 

 WHITEPAPER - Formulating Custom Viscosity Blends With POLYOX™ Polyethylene Oxide 


Excipient variability plays a critical role in pharmaceutical product design. A risk-based, scientific approach to Quality by Design (QbD) is essential to ensure consistent drug performance.

Our latest whitepaper delves into the impact of POLYOX™ PEO (Polyethylene Oxide) on drug …

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

April 16 – Prefilled Syringes
April 23 – Particle Design Technology